Connect with us

Desoxyn

Company

Indications

  • treatment of Attention Deficit Disorder with Hyperactivity as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children over 6 years of age with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate to severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
  • treatment of Exogenous Obesity as a short-term (i.e., a few weeks) adjunct in a regimen of weight reduction based on caloric restriction, for patients in whom obesity is refractory to alternative therapy, e.g., repeated diets, group programs, and other drugs.

Daily Posts

CNS Drug: #CNSDOD
Notable Person: #BHCPOD
Phobia: #BNphobia
Term: #BHCTOD

National Conference #Hashtags

11/12-14 AMERSA
#AMERSA2026

11/12-15 AAAP
#AAAP2026

11/12-15 ABCT
#ABCTNOW

11/14-18 SfN
#SfN26

11/18-21 ACLP
#ACLP2026